Picato recall in Canada: potential increased risk of skin cancer
In plain language
This recall involves Picato (ingenol mebutate gel, 0.015% and 0.05%) sold in Canada. It's being recalled because of a potential increased risk of skin cancer. Stop using the product and contact your doctor to discuss other treatment options.
What to do
- Stop using the product immediately.
- Contact your doctor to discuss other treatment options.
- Report any signs of skin cancer to a healthcare professional.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Picato 0.015% gel
Model: DIN 2400987
Picato 0.05% gel
Model: DIN 2400995
Why this matters
Potential increased risk of skin cancer
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: DIN 2400987, DIN 2400995
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Potential increased risk of skin cancer
What should consumers do?
Stop using the product immediately. Contact your doctor to discuss other treatment options. Report any signs of skin cancer to a healthcare professional.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Potential increased risk of skin cancer
When was this product recalled?
This product was recalled on October 27, 2020.
Is the Picato brand affected by this recall?
Yes, Picato products are affected by this recall. This recall involves Picato (ingenol mebutate gel, 0.015% and 0.05%) sold in Canada. It's being recalled because of a potential increased risk of skin cancer. Stop using the product and contact your doctor to discuss other treatment options.